The emerging therapy of the medication represents a major advance in the management of the condition. Distinct from existing drugs, tirzepatide targets dual pathways – glucagon-like peptide-1 (GLP-1) and GIP – https://tirzepatide-peptide122585.blogdiloz.com/40597012/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment